Biopharmaceutical testing capabilities expanded in Lincolnshire, Illinois

SGS, a global leader in testing, inspection, and certification, has expanded its biopharmaceutical testing capabilities at its Lincolnshire, Illinois, centre of excellence. This facility, now further enhanced with new instrumentation and expertise, offers comprehensive analytical services to support pharmaceutical, biopharmaceutical, and medical device developers and manufacturers.

The Lincolnshire centre, a 60,000 ft² facility, provides microbiology, chemistry, and molecular biology services, catering to both small and large molecule testing needs across all stages of product development. With the recent expansion, SGS has introduced services such as early cell bank safety assessment, product characterisation, method development and validation, raw material testing, and final product release support.

The addition of advanced capabilities strengthens SGS’s position in the biopharmaceutical market, particularly in the characterisation of biologic therapeutics. The Lincolnshire facility now uniquely supports analytical testing from discovery through commercial stages, enabling clients to streamline their development processes with a single, flexible service provider.

“Biologics constitute a high-growth segment of the pharmaceutical market, with sales and development of biologics-based products more than doubling over the last decade in North America,” said Mark Rogers, Global Scientific Director, Health & Nutrition, SGS. “With the addition of scientific expertise and leading instrumentation at our Lincolnshire site, SGS is bolstering its biologics testing capabilities to better meet the growing demand for large molecule drug products that are supporting rapid advancements in novel drug discovery.”

SGS operates 20 laboratories across 11 countries that service the global biopharmacuetical/pharmaceutical industry which represents the broadest, wholly owned, global network of contract analytical laboratories for this sector. SGS also delivers solutions for medical-device developers and manufacturers, and also offers services in biostatistics and regulatory consultancy. 

More information online